RAFAEL
DÍAZ DE LA GUARDIA GUERRERO
Investigador en el periodo 1984-2009
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (9)
2024
2022
-
Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell
Stem Cells Translational Medicine, Vol. 11, Núm. 1, pp. 88-96
-
The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 6
2021
-
Engraftment characterization of risk-stratified AML in NSGS mice
Blood Advances, Vol. 5, Núm. 23, pp. 4842-4854
2020
-
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
Journal for immunotherapy of cancer, Vol. 8, Núm. 1
2019
-
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Leukemia, Vol. 33, Núm. 7, pp. 1557-1569
2018
2017
-
Proinflammatory signals are insufficient to drive definitive hematopoietic specification of human HSCs in vitro
Experimental Hematology, Vol. 45, pp. 85-93.e2
-
Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease
Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290